La depleción de células CD34+/CD144+ en pacientes de revascularización miocárdica no está mediada por un aumento de la apoptosis inducida por el TGF-beta plasmático

CABG patients possess a lower number of CD34+/CD144+ cells than valvular ones. Plasma from CABG patients is antiapoptotic for EOCs from healthy donors and increases the expression of both CD34 and CD144. Suboptimal number of CD34+/CD144+ in vivo may be mediated by a primary bone marrow defect rather than a deleterious effect of plasma.